← All stories
Markets

Kaplan Fox Reminds Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors with Significant Losses to Seek a Leadership Role Before Deadline on September 28, 2026

1 source ·1 article ·Aug 6, 14:49 UTC Capricor Therapeutics

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) on behalf of investors that purchas…

Covered by 1 outlet

All coverage · 1 article